Arrowstreet Capital, Limited Partnership Verastem, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.54 - $4.07 $33,782 - $54,131	-13,300 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.57 - $4.85 $34,181 - $64,504	13,300 New	13,300 $54,000
Q2 2019 Aug 14, 2019	SELL	$1.25 - $3.14 $36,375 - $91,374	-29,100 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$2.79 - $4.09 $327,077 - $479,478	-117,232 Reduced 80.11%	29,100 $86,000
Q4 2018 Feb 14, 2019	BUY	$3.23 - $7.01 $472,652 - $1.03 Million	146,332 New	146,332 $492,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.29B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.